506414 Stock Overview
Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Fermenta Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹181.80 |
| 52 Week High | ₹214.00 |
| 52 Week Low | ₹132.30 |
| Beta | -0.033 |
| 1 Month Change | 21.81% |
| 3 Month Change | 17.33% |
| 1 Year Change | 26.69% |
| 3 Year Change | -44.96% |
| 5 Year Change | -24.90% |
| Change since IPO | 1,718.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506414 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.0% | -0.1% | 1.8% |
| 1Y | 26.7% | 55.9% | 46.4% |
Return vs Industry: 506414 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 506414 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| 506414 volatility | |
|---|---|
| 506414 Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 506414 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506414's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 550 | Prashant Nagre | fermentabiotech.com |
Fermenta Biotech Limited, together with its subsidiaries, manufactures and markets chemicals, bulk drugs, and enzymes in India, Europe, the United States, and internationally. It also engages in the provision of pharmaceutical formulations and environmental solutions; development and rental of properties; and sports and health awareness/education activities. In addition, the company offers various variants of vitamin D3, including crystalline, oil, resin in oil, cold water dispersible, and feed grade powder for use in applications, such as pharmaceuticals, dietary and nutritional supplements, feed premixes, food and beverage fortification, and rodenticides; active pharmaceutical ingredients comprising of phenyramidol and silicon dry powder; nutritional premixes; and enzymes, which are used in pharmaceuticals, food and fragrances, oleo, biodiesel, leather, and fine chemical industries.
Fermenta Biotech Limited Fundamentals Summary
| 506414 fundamental statistics | |
|---|---|
| Market cap | ₹5.25b |
| Earnings (TTM) | -₹206.53m |
| Revenue (TTM) | ₹3.43b |
1.5x
P/S Ratio-25.4x
P/E RatioIs 506414 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506414 income statement (TTM) | |
|---|---|
| Revenue | ₹3.43b |
| Cost of Revenue | ₹1.53b |
| Gross Profit | ₹1.91b |
| Other Expenses | ₹2.11b |
| Earnings | -₹206.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.15 |
| Gross Margin | 55.54% |
| Net Profit Margin | -6.01% |
| Debt/Equity Ratio | 60.6% |
How did 506414 perform over the long term?
See historical performance and comparison